NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES
Mark Identification

NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES

Serial Number

97296549

Filing Date

Mar 4, 2022

Registration Date

May 23, 2023

Trademark by

ANGIEX INC.

Active Trademark

Classification Information

Scientific research and development in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; research and product development services for others in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; Medical and scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, and cardiovascular disease detection; Providing information on the subject of scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine

Computer and Scientific